Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Turning Point Therapeutics, Inc.
Nuvation Bio Inc.
Hoffmann-La Roche
EpicentRx, Inc.
University of California, San Francisco
Peking Union Medical College Hospital
University of Maryland, Baltimore